Johnson & Johnson Exceeds Earnings Estimates, Raises FY26 Outlook
Johnson & Johnson (JNJ) reported Q2 non-GAAP earnings per share of $2.90, surpassing estimates by $0.05 and revenue of $25.31 billion that beat expectations by $250 million. The company raised its FY26 outlook due to strong operational performance.
Tickers: $JNJ